COMP <GO>
BBNX vs MRK // 10Y YIELD & FRED MACRO BETA
Beta Bionics Inc. (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: BBNX 2
— MRK 9
■ METRIC PARITY
LAST: $16.75 (-4.72%) • MKT CAP: $955.8M
macro-sensitivity
—
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
macro-sensitivity
0.92
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BBNX VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BBNX | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 55.40% | 74.80% | -19.40 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -22.10% | 20.70% | -42.80 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -5.88% | 3.42% | -9.30 | MRK | /fcf-yield <GO> |
| Operating Margin | -60.00% | 34.30% | -94.30 | MRK | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 28.10% | -88.10 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 53.90% | 1.30% | +52.60 | BBNX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 12.82 | 5.19 | +7.63 | BBNX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.8 | 51.7 | -5.90 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $955.8M | $361.02B | -$360.07B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BBNX REV | MRK REV | BBNX GROSS % | MRK GROSS % | BBNX FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $100.3M | $65.01B | 55.4% | 74.8% | -$56.2M | $12.36B |
| FY 2024 | $65.1M | $64.17B | 55.1% | 76.3% | -$51.7M | $18.10B |
| FY 2023 | $12.0M | $60.12B | — | — | -$32.4M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BBNX // BETA —
MRK // BETA 0.92